Skip to main content

Diabetic Retinopathy clinical trials at UCSD
1 in progress, 0 open to new patients

  • Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

    Sorry, in progress, not accepting new patients

    To show the non-inferiority of EGRIFTA® vs. placebo in the development or progression of Diabetic Retinopathy in HIV-infected subjects with concomitant abdominal lipohypertrophy and Type 2 diabetes mellitus (T2DM).

    San Diego, California and other locations